Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Drug category
|
| gptkbp:administeredBy |
gptkb:Oral
gptkb:Injection Inhalation Transdermal patch |
| gptkbp:broadcastOn |
Schedule I (some, e.g., heroin, USA)
Schedule II (some, e.g., morphine, USA) Schedule III (some, e.g., codeine, USA) |
| gptkbp:canBeAbused |
Yes
|
| gptkbp:cause |
gptkb:Euphoria
gptkb:Nausea Addiction Constipation Tolerance Drowsiness Withdrawal symptoms Respiratory depression Physical dependence |
| gptkbp:derivedFrom |
gptkb:Opium_poppy
|
| https://www.w3.org/2000/01/rdf-schema#label |
Narcotic drugs
|
| gptkbp:includes |
gptkb:Codeine
gptkb:Heroin gptkb:Hydrocodone gptkb:Morphine gptkb:Oxycodone gptkb:Methadone Opium Fentanyl Natural opiates Semi-synthetic opioids Synthetic opioids |
| gptkbp:legalStatus |
Illegal without prescription (most countries)
Prescription only (most countries) |
| gptkbp:monitors |
gptkb:International_Narcotics_Control_Board
|
| gptkbp:overdoseCanCause |
death
|
| gptkbp:regulates |
gptkb:Single_Convention_on_Narcotic_Drugs_(1961)
gptkb:Controlled_Substances_Act_(USA) |
| gptkbp:subjectOf |
Drug overdose
Pain management Drug trafficking Drug policy Harm reduction Addiction treatment Opioid crisis Prescription drug monitoring |
| gptkbp:usedFor |
Pain relief
|
| gptkbp:bfsParent |
gptkb:Controlled_Substances_Schedules_I-V
|
| gptkbp:bfsLayer |
7
|